Amgen’s Bkemv Earns FDA Approval as First Interchangeable Biosimilar to Soliris

The FDA approved Amgen’s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to AstraZeneca’s Soliris (eculizumab) to treat the rare diseases paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).…

Continue ReadingAmgen’s Bkemv Earns FDA Approval as First Interchangeable Biosimilar to Soliris

ICH Issues Final Guidance on Drug Interactions, Draft Guidance on Drug Safety Studies

The final version of an International Council of Harmonisation (ICH) guideline that addresses evaluation of the drug-drug interaction (DDI) potential of an investigational drug is ready for adoption and a…

Continue ReadingICH Issues Final Guidance on Drug Interactions, Draft Guidance on Drug Safety Studies

Louisiana Law Classifies Mifepristone and Misoprostol as Controlled Substances

Believing “this bill protects women across Louisiana,” Gov. Jeff Landry on Friday signed state legislation classifying the abortion-inducing drugs mifepristone and misoprostol as controlled substances. Source: Drug Industry Daily

Continue ReadingLouisiana Law Classifies Mifepristone and Misoprostol as Controlled Substances